Omnicell has finalized an agreement for the acquisition of Ateb Inc. and its affiliate, Ateb Canada Ltd.
"This acquisition demonstrates Omnicell's commitment to supporting the growing shift in how patients receive services along the entire continuum of care, elevating the role of pharmacists in improving overall patient safety and outcomes," Omnicell President of Global Automation and Medication Adherence Rob Seim said. "Ateb's solutions are currently provided to over 15,000 pharmacies in the U.S. and Canada, and for a quarter of a century the company has been helping pharmacists—who are the most visible and accessible care providers in the community—fulfill their mission of serving patients."
Ateb’s portfolio will help Omnicell further its mission of increasing patients’ medication access.
"As the leader in helping pharmacies develop synchronization programs that improve the health of their patients, we believe today's announcement will help our customers continue to grow their adherence programs for the benefit of their patients," Ateb President and CEO Frank Sheppard said. "This integration creates a clear path between the various stages of successful adherence programs and is an instrumental step in making these offerings a more routine and expected component of outpatient care."